Leonard M. Schiller - 13 Jun 2022 Form 4/A - Amendment Insider Report for MILESTONE SCIENTIFIC INC. (MLSS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4/A - Amendment
Accepted by SEC
11 Oct 2022, 18:48:35 UTC
Original report date
15 Jun 2022
Prior SEC filing
06 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leonard Schiller

Key filing fact

Leonard M. Schiller filed Form 4/A - Amendment for MILESTONE SCIENTIFIC INC. (MLSS) on 11 Oct 2022.

Key facts

  • This page summarizes Leonard M. Schiller's Form 4/A - Amendment filing for MILESTONE SCIENTIFIC INC. (MLSS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Oct 2022, 18:48.

Change

  • Previous filing in this sequence was filed on 06 Apr 2022.
  • Current net transaction value: +$105,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MLSS transaction

Common Stock, Par Value $0.001

Award

Transaction value
$105,000
Shares
+128,049
Change %
+42%
Price
$0.8200
Shares after
434,449
Date
13 Jun 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock valued as of the close of business on the grant date of June 14, 2022, with one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2022, January 1, 2023, and April 1, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .